Literature DB >> 21467165

Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.

Maya Zigler1, Gabriel J Villares, Andrey S Dobroff, Hua Wang, Li Huang, Russell R Braeuer, Takafumi Kamiya, Vladislava O Melnikova, Renduo Song, Ran Friedman, Rhoda M Alani, Menashe Bar-Eli.   

Abstract

The acquisition of the metastatic melanoma phenotype is associated with increased expression of the melanoma cell adhesion molecule MCAM/MUC18 (CD146). However, the mechanism by which MUC18 contributes to melanoma metastasis remains unclear. Herein, we stably silenced MUC18 expression in two metastatic melanoma cell lines, A375SM and C8161, and conducted cDNA microarray analysis. We identified and validated that the transcriptional regulator, inhibitor of DNA binding-1 (Id-1), previously shown to function as an oncogene in several malignancies, including melanoma, was downregulated by 5.6-fold following MUC18 silencing. Additionally, we found that MUC18 regulated Id-1 expression at the transcriptional level via ATF-3, which itself was upregulated by 6.9-fold in our cDNA microarray analysis. ChIP analysis showed increased binding of ATF-3 to the Id-1 promoter after MUC18 silencing. To complement these studies, we rescued the expression of MUC18, which reversed the expression patterns of Id-1 and ATF-3. Moreover, we showed that MUC18 promotes melanoma invasion through Id-1, as overexpression of Id-1 in MUC18-silenced cells resulted in increased MMP-2 expression and activity. To our knowledge, this is the first demonstration that MUC18 is involved in cell signaling regulating the expression of Id-1 and ATF-3, thus contributing to melanoma metastasis. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467165      PMCID: PMC3096710          DOI: 10.1158/0008-5472.CAN-10-3555

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.

Authors:  Jarnail Singh; Kenji Murata; Yoko Itahana; Pierre-Yves Desprez
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

2.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

Authors:  Yibin Kang; Chang-Rung Chen; Joan Massagué
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

3.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

5.  The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.

Authors:  D Polsky; A Z Young; K J Busam; R M Alani
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a.

Authors:  R M Alani; A Z Young; C B Shifflett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

Review 7.  Cell adhesion molecules in the development and progression of malignant melanoma.

Authors:  J P Johnson
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

8.  Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.

Authors:  T Qian; J-Y Lee; J-H Park; H-J Kim; G Kong
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

9.  Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.

Authors:  Lisa Mills; Carmen Tellez; Suyun Huang; Cheryl Baker; Marya McCarty; Larry Green; Jean M Gudas; X Feng; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

10.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Authors:  Sylvia Fong; Yoko Itahana; Tomoki Sumida; Jarnail Singh; Jean-Philippe Coppe; Yong Liu; Peter C Richards; James L Bennington; Nancy M Lee; Robert J Debs; Pierre-Yves Desprez
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

View more
  21 in total

1.  Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Authors:  Klervi Even-Desrumeaux; Damien Nevoltris; Marie Noelle Lavaut; Karima Alim; Jean-Paul Borg; Stéphane Audebert; Brigitte Kerfelec; Daniel Baty; Patrick Chames
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

2.  Decreased expression levels of cell cycle regulators and matrix metalloproteinases in melanoma from RET-transgenic mice by single irradiation of non-equilibrium atmospheric pressure plasmas.

Authors:  Machiko Iida; Yasuhiro Omata; Chihiro Nakano; Ichiro Yajima; Toyonori Tsuzuki; Kenji Ishikawa; Masaru Hori; Masashi Kato
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  MCAM knockdown impairs PPARγ expression and 3T3-L1 fibroblasts differentiation to adipocytes.

Authors:  Matías Gabrielli; Damián G Romero; Claudia N Martini; Laura Judith Raiger Iustman; María Del C Vila
Journal:  Mol Cell Biochem       Date:  2018-02-21       Impact factor: 3.396

4.  MCAM expression is associated with poor prognosis in non-small cell lung cancer.

Authors:  X Zhang; Z Wang; Y Kang; X Li; X Ma; L Ma
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

5.  Human fetal skeletal muscle contains a myogenic side population that expresses the melanoma cell-adhesion molecule.

Authors:  Ariya D Lapan; Anete Rozkalne; Emanuela Gussoni
Journal:  Hum Mol Genet       Date:  2012-05-24       Impact factor: 6.150

6.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  Non-thermal atmospheric pressure plasmas as a novel candidate for preventive therapy of melanoma.

Authors:  Yasuhiro Omata; Machiko Iida; Ichiro Yajima; Kozue Takeda; Nobutaka Ohgami; Masaru Hori; Masashi Kato
Journal:  Environ Health Prev Med       Date:  2014-07-19       Impact factor: 3.674

8.  Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.

Authors:  Hye Jin Jin; Ji Hye Kwon; Miyeon Kim; Yun Kyung Bae; Soo Jin Choi; Wonil Oh; Yoon Sun Yang; Hong Bae Jeon
Journal:  Stem Cells Transl Med       Date:  2016-03-03       Impact factor: 6.940

9.  Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model.

Authors:  Qiang Chen; Lei Chen; Ren Zhao; Xiao-dong Yang; Khan Imran; Chun-gen Xing
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-07       Impact factor: 4.553

10.  Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.

Authors:  Guang-Jer Wu
Journal:  Clin Exp Metastasis       Date:  2016-08-10       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.